Qingzhou Meng

625 total citations
12 papers, 505 citations indexed

About

Qingzhou Meng is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Qingzhou Meng has authored 12 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Immunology. Recurrent topics in Qingzhou Meng's work include CRISPR and Genetic Engineering (6 papers), Advanced biosensing and bioanalysis techniques (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Qingzhou Meng is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Advanced biosensing and bioanalysis techniques (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Qingzhou Meng collaborates with scholars based in China and Rwanda. Qingzhou Meng's co-authors include Xingxu Huang, Xinjie Wang, Peixiang Ma, Guang Yang, Lu Dang, Mingtian Zhong, Jia Liu, Xiaodong Ma, Zifeng Yang and Liu Y and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Frontiers in Immunology.

In The Last Decade

Qingzhou Meng

11 papers receiving 500 citations

Peers

Qingzhou Meng
Jiaqi Gu China
Ekaterina Mokhonova United States
Nicole L. Welch United States
Meleana M. Hinchman United States
Yao Zhong China
Mahendran Chinnappan United States
Qingzhou Meng
Citations per year, relative to Qingzhou Meng Qingzhou Meng (= 1×) peers Toshihiro Yonekawa

Countries citing papers authored by Qingzhou Meng

Since Specialization
Citations

This map shows the geographic impact of Qingzhou Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingzhou Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingzhou Meng more than expected).

Fields of papers citing papers by Qingzhou Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingzhou Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingzhou Meng. The network helps show where Qingzhou Meng may publish in the future.

Co-authorship network of co-authors of Qingzhou Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingzhou Meng. A scholar is included among the top collaborators of Qingzhou Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingzhou Meng. Qingzhou Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Zhong, Mingtian, Wenjun Sun, Xiangyang Li, et al.. (2022). PCDetection: PolyA-CRISPR/Cas12a-based miRNA detection without PAM restriction. Biosensors and Bioelectronics. 214. 114497–114497. 36 indexed citations
3.
Zhang, Guiquan, Qingzhou Meng, Shisheng Huang, et al.. (2022). Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors. Nature Communications. 13(1). 1454–1454. 10 indexed citations
4.
Meng, Qingzhou, Haixiang Sun, & Jianghuai Liu. (2022). Precise somatic genome editing for treatment of inborn errors of immunity. Frontiers in Immunology. 13. 960348–960348. 2 indexed citations
5.
Meng, Qingzhou, Guiquan Zhang, Wenjun Sun, et al.. (2021). CRISPR/Cas12a-assisted rapid identification of key beer spoilage bacteria. Innovative Food Science & Emerging Technologies. 74. 102854–102854. 9 indexed citations
6.
Meng, Qingzhou, Xinjie Wang, Yanqun Wang, et al.. (2021). Detection of the SARS‐CoV‐2 D614G mutation using engineered Cas12a guide RNA. Biotechnology Journal. 16(6). e2100040–e2100040. 36 indexed citations
7.
Wang, Xinjie, Mingtian Zhong, Liu Y, et al.. (2020). Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER. Science Bulletin. 65(17). 1436–1439. 163 indexed citations
8.
Ma, Peixiang, Qingzhou Meng, Baoqing Sun, et al.. (2020). MeCas12a, a Highly Sensitive and Specific System for COVID‐19 Detection. Advanced Science. 7(20). 2001300–2001300. 123 indexed citations
9.
Jiang, Hui, Hengfei Shi, Qingzhou Meng, et al.. (2016). PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense. The Journal of Immunology. 197(7). 2880–2890. 94 indexed citations
10.
Du, Yinan, Qingzhou Meng, Bin Shen, et al.. (2015). Functional annotation of cis-regulatory elements in human cells by dCas9/sgRNA. Cell Research. 25(7). 877–880. 5 indexed citations
11.
Zhu, Yi, et al.. (2014). Spa adjuvant therapy improves diabetic lower extremity arterial disease. Complementary Therapies in Medicine. 22(4). 655–661. 15 indexed citations
12.
Wang, Caiping, Qingzhou Meng, Fei Li, et al.. (2013). Cyclosporin A attenuates weight gain and improves glucose tolerance in diet-induced obese mice. Molecular and Cellular Endocrinology. 370(1-2). 96–102. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026